To include your compound in the COVID-19 Resource Center, submit it here.

Granulysin skin game

Researchers in Taiwan have identified a cytotoxic protein, granulysin, that could be targeted to treat or diagnose Stevens-Johnson syndrome and toxic epidermal necrosis.1 The data suggest the protein is a central player in the skin cell necrosis seen in patients with these conditions.

Stevens-Johnson syndrome (SJS) and toxic epidermal necrosis (TEN) are cutaneous eruptions caused by adverse drug reactions and have a mortality rate of 10-50%.2 Mechanistically, both are considered variants in severity of the same condition: SJS is characterized by <10% skin detachment, TEN by >30% detachment and overlapping SJS and TEN by 10-30% detachment.3

The reactions have been linked to the use of many drugs, with most reports being related to anticonvulsants, antibiotics and NSAIDs.4 SJS risks contributed

Read the full 1180 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers